These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 3825252

  • 1. [Immunohistochemical characterization of renal cell carcinomas].
    Bohle B, Waldherr R, Schwechheimer K, Moldenhauer G, Momburg F.
    Verh Dtsch Ges Pathol; 1986; 70():274-8. PubMed ID: 3825252
    [No Abstract] [Full Text] [Related]

  • 2. Cellular origin of renal cell carcinoma--an immunohistological study on monoclonal antibodies.
    Gu FL, Cai SL, Cai BJ, Wu CP.
    Scand J Urol Nephrol Suppl; 1991; 138():203-6. PubMed ID: 1785005
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibody to a proximal nephrogenic renal antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human renal cell carcinomas.
    Yoshida SO, Imam A.
    Cancer Res; 1989 Apr 01; 49(7):1802-9. PubMed ID: 2466563
    [Abstract] [Full Text] [Related]

  • 4. Antigen expression in renal cell carcinoma. Correlation with histological grade, pathological stage and development of distant metastasis.
    Reuter VE.
    Eur Urol; 1990 Apr 01; 18 Suppl 2():4-5. PubMed ID: 2226607
    [No Abstract] [Full Text] [Related]

  • 5. HLA class I expression in primary and metastatic renal cell carcinoma.
    Buszello H, Ackermann R.
    Investig Urol (Berl); 1994 Apr 01; 5():55-9. PubMed ID: 7719321
    [No Abstract] [Full Text] [Related]

  • 6. Circulating cancer cells in renal-cell carcinoma.
    Pontes JE, Pescatori E, Connelly R, Hashimura T, Tubbs R.
    Prog Clin Biol Res; 1990 Apr 01; 348():1-12. PubMed ID: 2385602
    [No Abstract] [Full Text] [Related]

  • 7. Monoclonal antibodies to renal cancer antigens.
    Bander NH.
    Semin Urol; 1989 Nov 01; 7(4):264-70. PubMed ID: 2694262
    [No Abstract] [Full Text] [Related]

  • 8. Antigen diffusion and uptake: a caveat in immunohistochemical interpretation.
    Alpern HD.
    Mod Pathol; 1992 Sep 01; 5(5):575-6. PubMed ID: 1344823
    [Abstract] [Full Text] [Related]

  • 9. Development and characterization of anti-renal cell carcinoma x antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinoma.
    Kranenborg MH, Boerman OC, Oosterwijk-Wakka JC, de Weijert MC, Corstens FH, Oosterwijk E.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5864s-5867s. PubMed ID: 7493361
    [Abstract] [Full Text] [Related]

  • 10. A comparison of A103 and inhibin reactivity in adrenal cortical tumors: distinction from hepatocellular carcinoma and renal tumors.
    Renshaw AA, Granter SR.
    Mod Pathol; 1998 Dec 01; 11(12):1160-4. PubMed ID: 9872645
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical analysis of tumor antigen saturation following injection of monoclonal antibody G250.
    Steffens MG, Oosterwijk-Wakka JC, Zegwaart-Hagemeier NE, Boerman OC, Debruyne FM, Corstens FH, Oosterwijk E.
    Anticancer Res; 1999 Dec 01; 19(2A):1197-200. PubMed ID: 10368675
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
    Brasanac D, Marković-Lipkovski J, Hadzi-Djokić J, Müller GA, Müller CA.
    Neoplasma; 1999 Dec 01; 46(3):173-8. PubMed ID: 10613593
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibodies to human renal cell carcinoma: recognition of shared and restricted tissue antigens.
    Vessella RL, Moon TD, Chiou RK, Nowak JA, Arfman EW, Palme DF, Peterson GA, Lange PH.
    Cancer Res; 1985 Dec 01; 45(12 Pt 1):6131-9. PubMed ID: 3904980
    [Abstract] [Full Text] [Related]

  • 14. [Histogenesis of renal cell carcinoma].
    Brasanac D, Todorović V, Knezević-Usaj S, Markovic-Lipkovski J.
    Med Pregl; 1996 Dec 01; 49(1-2):23-5. PubMed ID: 8643065
    [Abstract] [Full Text] [Related]

  • 15. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
    Inamoto T, Yamochi T, Ohnuma K, Iwata S, Kina S, Inamoto S, Tachibana M, Katsuoka Y, Dang NH, Morimoto C.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3470-7. PubMed ID: 16740772
    [Abstract] [Full Text] [Related]

  • 16. [Expression of LeX antigens in renal adenocarcinoma differentiation and the prognosis].
    Fukushi Y, Saito S, Orikasa S, Ohtani H.
    Nihon Hinyokika Gakkai Zasshi; 1988 Jun 01; 79(6):1090-5. PubMed ID: 2903265
    [No Abstract] [Full Text] [Related]

  • 17. Monoclonal antibodies to renal cancer antigens.
    Bander NH.
    Eur Urol; 1990 Jun 01; 18 Suppl 2():10-2. PubMed ID: 2226594
    [No Abstract] [Full Text] [Related]

  • 18. A highly restricted antigen for renal cell carcinoma defined by a monoclonal antibody.
    Moon TD, Vessella RL, Palme DF, Nowak JA, Lange PH.
    Hybridoma; 1985 Jun 01; 4(2):163-71. PubMed ID: 3891589
    [Abstract] [Full Text] [Related]

  • 19. Collecting duct carcinoma of the kidney: an immunohistochemical evaluation of the use of antibodies for differential diagnosis.
    Kobayashi N, Matsuzaki O, Shirai S, Aoki I, Yao M, Nagashima Y.
    Hum Pathol; 2008 Sep 01; 39(9):1350-9. PubMed ID: 18602672
    [Abstract] [Full Text] [Related]

  • 20. [Immunohistochemical study of renal cell carcinoma with monoclonal anti Leu-M1 antibody].
    Senga Y, Satomi Y, Fukuda M, Ebato T, Hosaka M, Tanaka Y, Misugi K.
    Nihon Hinyokika Gakkai Zasshi; 1987 Jul 01; 78(7):1246-51. PubMed ID: 3500350
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.